Opnet Technologies Inc.https://investorshangout.com/Opnet-Technologies-Inc-OPNT-54992/en-usFri, 04 Sep 2026 02:25:43 GMTCopyright InvestorsHangout.comwhytestocks: $OPNT News Article - OPNT Alert: Monsey Firm of Wohl & Fruchter LLP Investigating Sale of Opiant Phahttps://investorshangout.com/post/view?id=6497961https://investorshangout.com/post/view?id=6497961Mon, 14 Nov 2022 18:25:51 GMTwhytestocks: $OPNT News Article - Party City Layoffs 2022: What to Know About the PRTY Job Cuts https://investorshangout.com/post/view?id=6497904https://investorshangout.com/post/view?id=6497904Mon, 14 Nov 2022 16:35:48 GMTwhytestocks: $OPNT News Article - SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Opiant Pharmahttps://investorshangout.com/post/view?id=6497833https://investorshangout.com/post/view?id=6497833Mon, 14 Nov 2022 15:15:47 GMTwhytestocks: $OPNT News Article - Indivior PLC to Acquire Opiant Pharmaceuticals https://investorshangout.com/post/view?id=6497826https://investorshangout.com/post/view?id=6497826Mon, 14 Nov 2022 15:01:56 GMTwhytestocks: $OPNT News Article - Indivior To Acquire Opiant Pharmaceuticals https://investorshangout.com/post/view?id=6497823https://investorshangout.com/post/view?id=6497823Mon, 14 Nov 2022 14:55:47 GMTwhytestocks: $OPNT News Article - Opiant Pharmaceuticals Announces Notice of Allowance for U.S. Patent with Claimhttps://investorshangout.com/post/view?id=6459041https://investorshangout.com/post/view?id=6459041Mon, 22 Aug 2022 20:15:50 GMTwhytestocks: $OPNT News Article - Opiant Pharmaceuticals Initiates Rolling Submission of New Drug Application to https://investorshangout.com/post/view?id=6413884https://investorshangout.com/post/view?id=6413884Wed, 01 Jun 2022 20:35:54 GMTwhytestocks: $OPNT News Article - Opiant Pharmaceuticals Issues Statement in Response to Fake Press Release https://investorshangout.com/post/view?id=6393315https://investorshangout.com/post/view?id=6393315Fri, 29 Apr 2022 16:55:51 GMTwhytestocks: $OPNT News Article - Opiant Pharmaceuticals Announces Positive Pharmacokinetic, Safety, and Tolerabihttps://investorshangout.com/post/view?id=6341213https://investorshangout.com/post/view?id=6341213Thu, 10 Feb 2022 17:35:51 GMTwhytestocks: $OPNT News Article - Watch for Continued Gains in Shares of Opiant Pharmaceuticals Inc. (OPNT) https://investorshangout.com/post/view?id=6245465https://investorshangout.com/post/view?id=6245465Tue, 21 Sep 2021 17:25:50 GMTwhytestocks: $OPNT News Article - Opiant Pharmaceuticals Inc.: The Winning Streak Continues (OPNT) https://investorshangout.com/post/view?id=6241956https://investorshangout.com/post/view?id=6241956Thu, 16 Sep 2021 17:25:53 GMTwhytestocks: $OPNT News Article - Opiant Pharmaceuticals Announces Appointment of Matthew Ruth as Chief Commerciahttps://investorshangout.com/post/view?id=6181606https://investorshangout.com/post/view?id=6181606Mon, 12 Jul 2021 12:25:47 GMTwhytestocks: $OPNT News Article - Opiant Pharmaceuticals Strengthens Board of Directors With Appointment of Seasohttps://investorshangout.com/post/view?id=6088315https://investorshangout.com/post/view?id=6088315Mon, 22 Mar 2021 20:10:49 GMTwhytestocks: $OPNT News Article - Opiant Pharmaceuticals Announces Development Collaboration with National Centerhttps://investorshangout.com/post/view?id=5632532https://investorshangout.com/post/view?id=5632532Thu, 02 Jan 2020 16:50:42 GMT